Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bonyf NVXPAR:MLBON 23 EV-to-EBITDA is -228.53 as of Sep. 01, 2026. GuruFocus rates XPAR:MLBON with a GF Score™ of 23/100. The stock has 2 warning signs investors should review. Among 519 Medical Devices & Instruments companies, Bonyf NV ranks worse than 192678.03% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Bonyf NV's enterprise value is €7.77 Mil.
Bonyf NV's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.03 Mil. Therefore, Bonyf NV's EV-to-EBITDA for today is -228.53.
The historical rank and industry rank for Bonyf NV's EV-to-EBITDA or its related term are showing as below:
XPAR:MLBON'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -330.06 Med: -78.52 Max: 1895.13
Current: -228.53
During the past 5 years, the highest EV-to-EBITDA of Bonyf NV was 1895.13. The lowest was -330.06. And the median was -78.52.
XPAR:MLBON's EV-to-EBITDA is ranked worse than 100% of 519
companies
in the Medical Devices & Instruments industry
Industry Median: 14.48
vs XPAR:MLBON: -228.53
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Bonyf NV's share price for today is €2.48.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Bonyf NV's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was €0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Bonyf NV's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bonyf NV EV-to-EBITDA Chart
Bonyf NV Annual Data
Trend
Dec19
Dec20
Dec22
Dec23
Dec24
EV-to-EBITDA
0.00
0.00
-26.47
-178.33
-312.74
Bonyf NV Semi-Annual Data
Dec19
Dec20
Dec22
Dec23
Dec24
EV-to-EBITDA
0.00
0.00
-26.47
-178.33
-312.74
XPAR:MLBON vs ISRG, BDX, RMD: EV-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, Bonyf NV's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bonyf NV EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bonyf NV's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Bonyf NV's EV-to-EBITDA falls into.
Bonyf NV's current Enterprise Value is €7.77 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Bonyf NV's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.03 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bonyf NV (XPAR:MLBON) has a EV-to-EBITDA of -228.53 as of Sep. 01, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Bonyf NV. According to the industry distribution chart, Bonyf NV ranks #999999 out of 519 companies in the Medical Devices & Instruments industry.
Is Bonyf NV's EV-to-EBITDA too high?
Bonyf NV's current EV-to-EBITDA is -228.53. Based on the distribution chart, Bonyf NV ranks #999999 out of 519 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Bonyf NV has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Bonyf NV's EV-to-EBITDA compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bonyf NV ranks #999999 out of 519 companies for EV-to-EBITDA. This places Bonyf NV in the lower half of its industry. The industry median EV-to-EBITDA is 14.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.48, based on 519 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Bonyf NV. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bonyf NV's current EV-to-EBITDA is -228.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonyf NV stock overvalued right now?
Bonyf NV (XPAR:MLBON) has a current EV-to-EBITDA of -228.53. The current EV-to-EBITDA is -228.53. Bonyf NV's overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Bonyf NV (XPAR:MLBON), the current EV-to-EBITDA is -228.53 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bonyf NV specializes in developing, producing and selling cutting-edge oral & dental care products. It is a forward-thinking company committed to revolutionizing oral care through innovation and research.
23GF Score
Get the complete analysis for XPAR:MLBON
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:MLBON has been successfully added to your 
